|
|
|
|
|
| Parenterals Articles |
| Title (Click for Abstract / Details) |
Author |
Issue |
Page |
View/Buy |
| Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection |
Allen Loyd V Jr
|
May/Jun 2022 |
219-228 |
Buy |
| Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine |
Catry Emilie, Colsoul Marie-Louise, Closset Melanie, Hubert Justine, Soumoy Laura, Bihin Benoit, Thiry Emmanuell, Jamart Jacques, Hecq Jean-Daniel, Galanti Laurence
|
May/Jun 2022 |
248-254 |
Buy |
| Sterile Basics of Compounding: Methods of Sterilization and Depyrogenation |
Allen Loyd V Jr
|
Mar/Apr 2022 |
129-136 |
Buy |
| Calculations |
Stockton Shelly J
|
Mar/Apr 2022 |
138 |
Buy |
| Pharmacy Student Satisfaction and Perceptions Following a Virtual Sterile Compounding Experience |
Mohammad Insaf, Lobkovich Alison, Nardolillo Joseph, Wilhelm Shelia
|
Jan/Feb 2022 |
10-17 |
Buy |
| Microwave Freeze-thaw Technique for Injectable Drugs: A Review Updated from 1980 to 2021 |
Hecq Jean-Daniel, Soumoy Laura, Closset Mélanie, Colsoul Marie-Lise, Jamart Jacques, Galanti Laurence
|
Nov/Dec 2021 |
446-462 |
Buy |
| Compounding Robots for Intravenous Therapy in European Countries: A Review in 2020 |
Hecq Jean-Daniel, Soumoy Laura
|
Nov/Dec 2021 |
510-514 |
Buy |
| Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 11: Particulate Issues --- Silicone Oil in Vials, Cartridges, and Syringes |
Allen Loyd V Jr
|
Sep/Oct 2021 |
403-408 |
Buy |
| Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation |
Allen Loyd V Jr
|
May/Jun 2021 |
222-229 |
Buy |
| Calculations |
Stockton Shelly J
|
May/Jun 2021 |
230-231 |
Buy |
| Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation |
Allen Loyd V Jr
|
Mar/Apr 2021 |
131-139 |
Buy |
| Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4 |
Allen Loyd V Jr
|
Jan/Feb 2021 |
42 |
Buy |
| Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design |
Patel Gopesh, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S
|
Jan/Feb 2021 |
73-81 |
Buy |
| Establishing a Structured Pharmacy Training Program in Sterile Compounding |
Dirbas Muhannad, AbuSara Aseel K, Whiyabi Shatha, Harb Rema, Telfah Shorouq
|
Nov/Dec 2020 |
460-465 |
Buy |
| Intravenous Admixture Preparation Considerations, Part 7: Stability Issues |
Allen Loyd V Jr
|
Nov/Dec 2020 |
473-478 |
Buy |
| Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 7: Compounding with Surfactants |
Allen Loyd V Jr
|
Sep/Oct 2020 |
388-395 |
Buy |
| Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications |
Allen Loyd V Jr
|
Sep/Oct 2020 |
397-402 |
Buy |
| Biotin Regulates Colonization and Growth of Candida albicans in the Catheter Lumen During Nutrient Infusions |
Ohara Hiroshi, Matsuzaki Tetsuya, Ochiai Tatsuya, Hayasaka Masataka
|
Sep/Oct 2020 |
420-425 |
Buy |
| Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations |
Allen Loyd V Jr
|
Jul/Aug 2020 |
305-309 |
Buy |
| Quality Control: Photostability of Compounded Preparations |
Allen Loyd V Jr
|
May/Jun 2020 |
200-205 |
Buy |
| Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates |
Allen Loyd V Jr
|
May/Jun 2020 |
215-220 |
Buy |
| Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities |
Allen Loyd V Jr
|
Mar/Apr 2020 |
121-126 |
Buy |
| Physicochemical Stability of Ternary Mixtures of Sufentanil, Baclofen, and Ropivacaine in Polypropylene Syringes for Intrathecal Analgesia |
Sorrieul Jérémy, Robert Julien, Chapel Fanny, Gossye Thomas, Devys Catherine
|
Mar/Apr 2020 |
156-162 |
Buy |
| How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems |
Vaughn Stacey R, Radwick Allison
|
Jan/Feb 2020 |
14-19 |
Buy |
| Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved |
Allen Loyd V Jr
|
Jan/Feb 2020 |
44-50 |
Buy |
| Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators |
Mulder Kyle
|
Nov/Dec 2019 |
447-452 |
Buy |
| Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding |
Allen Loyd V Jr
|
Nov/Dec 2019 |
478-482 |
Buy |
| Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding |
Allen Loyd V Jr
|
Sep/Oct 2019 |
399-402 |
Buy |
| Stability of Furosemide 5 mg/mL in Polypropylene Syringes |
van der Schaar JAJ, Grouls R, Franssen EJF, Crul M
|
Sep/Oct 2019 |
414-417 |
Buy |
| Basics of Compounding: Standardization of Compounded Medications |
Allen Loyd V Jr
|
Jan/Feb 2019 |
35-44 |
Buy |
| PreScription: Standardized Concentrations: Pro or Con? |
Allen Loyd V Jr
|
Nov/Dec 2018 |
444 |
Buy |
| Long-term Physicochemical Stability of Concentrated Solutions of Noradrenaline Bitartrate in Polypropylene Syringes for Administration in the Intensive Care Unit |
Lardinois Benjamin, Pector Johan, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin B, Hecq Jean-Daniel, Galanti Laurence M
|
Jul/Aug 2018 |
335-339 |
Buy |
| Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture |
Allen Loyd V Jr
|
May/Jun 2018 |
237 |
Buy |
| Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy |
Kosinski Tracy M, Brown Michael C, Zavala Pedro J
|
Jan/Feb 2018 |
41-46 |
Buy |
| Haloperidol 5-mg/mL Injection |
Allen Loyd V Jr
|
Nov/Dec 2017 |
493 |
Buy |
| Trace Elements Injection 5 |
Allen Loyd V Jr
|
Nov/Dec 2017 |
498 |
Buy |
| Vancomycin 5-mg/mL Injection |
Allen Loyd V Jr
|
Nov/Dec 2017 |
499 |
Buy |
| Auditing Safety of Compounding and Reconstituting of Intravenous Medicines on Hospital Wards in Finland |
Suvikas-Peltonen Eeva, Palmgren Joni, Häggman Verner, Celikkayalar Ercan, Manninen Raija, Airaksinen Marja
|
Nov/Dec 2017 |
518-529 |
Buy |
| Calculations |
Stockton Shelly J
|
Sep/Oct 2017 |
406 |
Buy |
| Ioversol Injection |
Allen Loyd V Jr
|
Sep/Oct 2017 |
413 |
Buy |
| Basics of Sterile Compounding: Excipients Used in Injections |
Akers Michael J
|
Jul/Aug 2017 |
301-308 |
Buy |
| Accuracy Considerations in Sterile Compounding |
Akers Michael J
|
Mar/Apr 2017 |
133-142 |
Buy |
| Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms |
Akers Michael J
|
Jan/Feb 2017 |
47-56 |
Buy |
| Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate |
Wu George, Yeung Stanley, Chen Frank
|
Jan/Feb 2017 |
66-75 |
Buy |
| Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride |
Wu George, Yeung Stanley, Chen Frank
|
Jan/Feb 2017 |
76-82 |
Buy |
| Basics of Compounding: Clinical Pharmaceutics, Part 2 |
Allen Loyd V Jr
|
Nov/Dec 2016 |
485-493 |
Buy |
| Flumazenil 0.1-mg/mL Injection |
Allen Loyd V Jr
|
Nov/Dec 2016 |
509 |
Buy |
| Tromethamine Injection |
Allen Loyd V Jr
|
Sep/Oct 2016 |
415 |
Buy |
| Dolasetron Mesylate 20-mg/mL Injection |
Allen Loyd V Jr
|
Jul/Aug 2016 |
318 |
Buy |
| Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures |
Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE
|
Jul/Aug 2016 |
328-332 |
Buy |
| Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump |
Tomasello Cristina, Leggieri Anna, Rabbia Franco, Veglio Franco, Baietto Lorena, Fulcheri Chiara, De Nicolò Amedeo, De Perri Giovanni, D'Avolio Antonio
|
Jul/Aug 2016 |
343-346 |
Buy |
| Does Your Drug Expertise Include Clinical Pharmaceutics? |
Newton David W
|
May/Jun 2016 |
202-206 |
Buy |
| Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration |
Akers Michael J
|
May/Jun 2016 |
217-222 |
Buy |
| Carboplatin 50-mg/mL Injection |
Allen Loyd V Jr
|
May/Jun 2016 |
226 |
Buy |
| Cefotetan Disodium Injection |
Allen Loyd V Jr
|
May/Jun 2016 |
227 |
Buy |
| Sodium Nitroprusside 25-mg/mL Injection |
Allen Loyd V Jr
|
May/Jun 2016 |
234 |
Buy |
| Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration |
Mody Vicky, Shah Samit, Patel Jaymin, Thomas Michael C
|
May/Jun 2016 |
236-238 |
Buy |
| Formulation and Stability of Solutions |
Akers Michael J
|
Mar/Apr 2016 |
137-141 |
Buy |
| Calculations |
Stockton Shelly J
|
Mar/Apr 2016 |
142 |
Buy |
| Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal) |
Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
|
Mar/Apr 2016 |
148-154 |
Buy |
| Basic Principles of Lyophilization, Part 2 |
Akers Michael J
|
Jan/Feb 2016 |
20-27 |
Buy |
| Formulation and Stability of Solutions |
Akers Michael J
|
Jan/Feb 2016 |
41-45 |
Buy |
| Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems |
Akers Michael J
|
Nov/Dec 2015 |
491-500 |
Buy |
| Calculations |
Stockton Shelly J
|
Nov/Dec 2015 |
502 |
Buy |
| Ammonium Molybdate 25-mcg/mL Injection |
Allen Loyd V
|
Jul/Aug 2015 |
324 |
Buy |
| Oxytocin 10-units/mL Injection |
Allen Loyd V
|
Jul/Aug 2015 |
330 |
Buy |
| Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters |
Puertos Enrique, Spencer Melissa
|
Jul/Aug 2015 |
334-336 |
Buy |
| Deferoxamine Mesylate 213/mg/mL or 95-mg/mL Injection |
Allen Loyd V Jr
|
Mar/Apr 2015 |
144 |
Buy |
| Morrhuate Sodium 5% Injection |
Allen Loyd V Jr
|
Mar/Apr 2015 |
147 |
Buy |
| Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms |
Akers Michael J
|
Nov/Dec 2014 |
479-484 |
Buy |
| Basics of Compounding Sterile Preparations: Nomenclature and Considerations |
Allen Loyd V Jr
|
Jul/Aug 2014 |
313-317 |
Buy |
| Atracurium Besylate 10-mg/mL Injection, Preserved |
Allen Loyd V Jr
|
Jul/Aug 2014 |
322 |
Buy |
| Calcitriol 1-mcg/mL Injection |
Allen Loyd V Jr
|
Jul/Aug 2014 |
324 |
Buy |
| Chloramphenicol 100-mg/mL Injection |
Allen Loyd V Jr
|
Jul/Aug 2014 |
325 |
Buy |
| Indigo Carmine Injection |
Allen Loyd V Jr
|
Jul/Aug 2014 |
329 |
Buy |
| Propranolol Hydrochloride 1-mg/mL Injection |
Allen Loyd V Jr
|
Jul/Aug 2014 |
330 |
Buy |
| Zinc 1-mg/mL Injection |
Allen Loyd V Jr
|
Jul/Aug 2014 |
331 |
Buy |
| A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards |
Marks Zach
|
Mar/Apr 2014 |
94-99 |
Buy |
| Calculations |
Stockton Shelly J
|
Mar/Apr 2014 |
140-141 |
Buy |
| Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride |
Weeks Phillip A, Teng Yang, Wu Lei, Sun Mary, Yang Zhen, Chow Diana S-L
|
Mar/Apr 2014 |
152-158 |
Buy |
| Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents |
Logomasini Mark A, Stout Richard R, Ron Marcinkoski
|
Jul/Aug 2013 |
270-280 |
Buy |
| Allopurinol Sodium 4-mg/mL Injection |
Allen Loyd V Jr
|
Jul/Aug 2013 |
328 |
Buy |
| Amikacin Sulfate 250-mg/mL Injection |
Allen Loyd V Jr
|
Jul/Aug 2013 |
329 |
Buy |
| Dacarbazine 200-mg/mL Injection |
Allen Loyd V Jr
|
Jul/Aug 2013 |
330 |
Buy |
| Ketamine 50-mg/mL Injection |
Allen Loyd V Jr
|
Jul/Aug 2013 |
331 |
Buy |
| Methohexital Sodium 500-mg/mL Injection |
Allen Loyd V Jr
|
Jul/Aug 2013 |
332 |
Buy |
| Metoprolol Tartrate 1-mg/mL Injection |
Allen Loyd V Jr
|
Jul/Aug 2013 |
333 |
Buy |
| Succinylcholine Chloride 50-mg/mL Injection |
Allen Loyd V Jr
|
Jul/Aug 2013 |
335 |
Buy |
| Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists |
Macklin Denise, Blackburn Paul L
|
Mar/Apr 2013 |
100-110 |
Buy |
| Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings |
Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
|
Mar/Apr 2013 |
168-174 |
Buy |
| Desmopressin 4-mcg/mL Injection |
Allen Loyd V Jr
|
Jan/Feb 2013 |
64 |
Buy |
| Dobutamine 10-mg/mL Injection |
Allen Loyd V Jr
|
Jan/Feb 2013 |
65 |
Buy |
| Granisetron 1-mg/mL Injection |
Allen Loyd V Jr
|
Jan/Feb 2013 |
66 |
Buy |
| Ibuprofen 10-mg/mL Injection |
Allen Loyd V Jr
|
Jan/Feb 2013 |
67 |
Buy |
| Mepivacaine Hydrochloride 1% Injection |
Allen Loyd V Jr
|
Jan/Feb 2013 |
68 |
Buy |
| Milrinone 0.2-mg/mL Injection |
Allen Loyd V Jr
|
Jan/Feb 2013 |
69 |
Buy |
| Neostigmine Methylsulfate 0.5-mg/mL Injection |
Allen Loyd V Jr
|
Jan/Feb 2013 |
70 |
Buy |
| Nicardipine Hydrochloride Injection |
Allen Loyd V Jr
|
Jan/Feb 2013 |
71 |
Buy |
| Octreotide 50-mcg/mL Injection |
Allen Loyd V Jr
|
Jan/Feb 2013 |
72 |
Buy |
| Testosterone Cypionate 100-mg/mL Injection |
Allen Loyd V Jr
|
Jan/Feb 2013 |
73 |
Buy |
| Calculations |
Stockton Shelly J, Saluja Hardeep Singh
|
Nov/Dec 2012 |
498-499 |
Buy |
| Aminophylline 25-mg/mL Injection |
Allen Loyd V Jr
|
Nov/Dec 2012 |
500 |
Buy |
| Ammonium Chloride 5-mEq/mL Injection |
Allen Loyd V Jr
|
Nov/Dec 2012 |
501 |
Buy |
| Azathioprine 10-mg/mL Injection |
Allen Loyd V Jr
|
Nov/Dec 2012 |
502 |
Buy |
| Copper 0.4-mg/mL Injection |
Allen Loyd V Jr
|
Nov/Dec 2012 |
503 |
Buy |
| Dipyridamole 5-mg/mL Injection |
Allen Loyd V Jr
|
Nov/Dec 2012 |
504 |
Buy |
| Dopamine Hydrochloride 80-mg/mL Injection |
Allen Loyd V Jr
|
Nov/Dec 2012 |
505 |
Buy |
| Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules |
Allen Loyd V Jr
|
Nov/Dec 2012 |
506 |
Buy |
| Papaverine Hydrochloride 30-mg/mL Injection |
Allen Loyd V Jr
|
Nov/Dec 2012 |
507 |
Buy |
| Valproate Sodium 100-mg/mL Injection |
Allen Loyd V Jr
|
Nov/Dec 2012 |
508 |
Buy |
| Vercuronium Bromide 1-mg/mL Injection |
Allen Loyd V Jr
|
Nov/Dec 2012 |
509 |
Buy |
| Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration |
Zhang Yang, Scarlett Cameron, Hutson Paul
|
Jan/Feb 2012 |
82-85 |
Buy |
| A Retrospective Observational Case Series Analysis of the Usage of Hydroxyprogesterone Caproate for the Prevention of Preterm Labor in Alabama Patients |
Nolan Sara M, Burgess Christopher A
|
Nov/Dec 2011 |
446-448 |
Buy |
| Home Infusion: Overview of the Infusion Patient-Care Process |
Kennedy Steve
|
Jul/Aug 2011 |
270-276 |
Buy |
| Stability of Ertapenem in an Elastomeric Infusion Device |
Phipps Stephen D, Peacock Gina F, Smith Douglas L
|
May/Jun 2011 |
252-254 |
Buy |
| Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations |
Jasti Bhaskara R, Saraf Poonam
|
May/Jun 2011 |
259-261 |
Buy |
| Home Infusion: Available Vascular Access Devices and Common Therapies |
Kennedy Steve, Williams LaVonn A
|
May/Jun 2011 |
183-188 |
Buy |
| Drug Compatibility and Stability in Dextrose vs Saline |
Newton David W
|
May/Jun 2011 |
190-192 |
Buy |
| Home Infusion Basics for the Non-Infusion Pharmacist |
Miron Karen E
|
Mar/Apr 2011 |
94-100 |
Buy |
| Home Infusion 101 |
Williams LaVonn A
|
Jan/Feb 2011 |
6-10 |
Buy |
| Maillard Reactions in Pharmaceutical Formulations and Human Health |
Newton David W
|
Jan/Feb 2011 |
32-40 |
Buy |
| Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 3: A Simplified Endotoxin Test Method for Compounded Sterile Preparations |
Cooper James F
|
Jan/Feb 2011 |
49-54 |
Buy |
| Home Infusion: Overcoming the Barriers to Entry |
Franklin David M
|
Nov/Dec 2010 |
450-455 |
Buy |
| Home Infusion Accreditation: Another Quality Recognition Branding Tool |
Canally Sandra C
|
Sep/Oct 2010 |
360-364 |
Buy |
| Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin |
Baker Daniel S, Waldrop Bruce, Arnold John
|
Jul/Aug 2010 |
346-349 |
Buy |
| Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 18: Verification of Automated Compounding Devices for Parenteral Nutrition Compounding and Finished Preparation Release Checks and Tests |
Allen Loyd V Jr, Okeke Claudia C
|
Mar/Apr 2010 |
142-149 |
Buy |
| Lamotrigine 25-mg/mL Injection |
Allen Loyd V Jr
|
Mar/Apr 2010 |
156 |
Buy |
| Metolazone 10-mg/mL Injection |
Allen Loyd V Jr
|
Mar/Apr 2010 |
157 |
Buy |
| Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector |
Khondkar Dristi, Chopra Poonam, McArter John P, Rosen Joseph A, Li S Kevin
|
Mar/Apr 2010 |
160-164 |
Buy |
| Evaluation of a Simple Method for Visual Detection of Microprecipitates in Blends of Parenteral Drug Solutions Using a Focussed (Tyndall) Light Beam |
Veggeland Turid, Brandl Martin
|
Jan/Feb 2010 |
78-81 |
Buy |
| Ionic Hydration Solution for Anti-Cancer Therapy |
Allen Loyd V Jr
|
Mar/Apr 2009 |
156 |
Buy |
| Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration |
Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel
|
Jan/Feb 2009 |
78-80 |
Buy |
| Equine Anesthesia: Triple Drip |
Davidson Gigi S
|
Sep/Oct 2008 |
402-404 |
Buy |
| Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration |
Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
|
Sep/Oct 2008 |
460-462 |
Buy |
| Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration |
Shields David E, Aclan Jennifer, Szatkowski Aaron
|
Sep/Oct 2008 |
463-466 |
Buy |
| Glycerin, Sterile |
Allen Loyd V Jr
|
Nov/Dec 2008 |
542 |
Buy |
| Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration |
Shields David E, Aclan Jennifer, Szatkowski Aaron
|
Nov/Dec 2008 |
553-557 |
Buy |
| Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration |
Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
|
Jul/Aug 2008 |
368-371 |
Buy |
| Chemical Stability of Naltrexone Hydrochloride Injection |
Gupta Vishnu D
|
May/Jun 2008 |
274-275 |
Buy |
| Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration |
Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A
|
May/Jun 2008 |
276-278 |
Buy |
| Chemical Stability of Tramadol Hydrochloride Injection |
Gupta Vishnu D
|
Mar/Apr 2008 |
161-162 |
Buy |
| Emetine Hydrochloride 30-mg/mL Injection |
Allen Loyd V Jr
|
Jan/Feb 2008 |
68 |
Buy |
| Flosulide 10-mg/mL Injection |
Allen Loyd V Jr
|
Jan/Feb 2008 |
69 |
Buy |
| Room Temperature Stability of Injectable Succinylcholine Dichloride |
Roy Julie J, Boismenu Daniel, Mamer Orval A, Nguyen Bao T, Forest Jean-Marc, Hildgen Patrice
|
Jan/Feb 2008 |
83-85 |
Buy |
| Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration |
Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
|
Nov/Dec 2007 |
520-524 |
Buy |
| Calculations: High-Technology Compounding and Investigational Dispensing |
Webb Sheldon D, Stockton Shelly J
|
Nov/Dec 2007 |
500-501 |
Buy |
| Lidocaine Hydrochloride 1.82% Buffered Injection |
Allen Loyd V Jr
|
Nov/Dec 2007 |
511 |
Buy |
| The Whales: A Pharmacist's Story |
Wills William R
|
Sep/Oct 2007 |
376-383 |
Buy |
| Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion |
Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A
|
Sep/Oct 2007 |
426-432 |
Buy |
| Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution |
Allen Loyd V Jr
|
Jul/Aug 2007 |
328 |
Buy |
| Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution |
Allen Loyd V Jr
|
Jul/Aug 2007 |
335 |
Buy |
| Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration |
Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
|
Jan/Feb 2007 |
82-85 |
Buy |
| Chemical Stability of Pyridoxine Hydrochloride 100-mg/mL Injection, Preservative Free |
Gupta Vishnu D
|
Jul/Aug 2006 |
318-319 |
Buy |
| Physical Assessments of Lipid Injectable Emulsions via Microscopy: A Comparison to Methods Proposed in the United States Pharmacopeia Chapter <729> |
Driscoll David F, Nehne Jorg, Horst Peterss, Klutsch Karsten, Bistrian Bruce R, Wilhelm Niemann
|
Jul/Aug 2006 |
309-315 |
Buy |
| Using ACDs in the Practice of Pharmacy |
Kastango Eric S
|
Jan/Feb 2005 |
15-21 |
Buy |
| PostScription: Cleanroom Standards |
Fitzpatrick Mike, Goldstein Ken
|
Mar/Apr 2004 |
160 |
Buy |
| Glycerin 50% Injection |
Allen Loyd V Jr
|
Jan/Feb 2004 |
54 |
Buy |
| Vancomycin HCl and Heparin Sodium Injection |
Allen Loyd V Jr
|
Jan/Feb 2004 |
60 |
Buy |
| Total Parenteral Nutrition for Animals |
Sammarco Domenic A
|
Sep/Oct 2002 |
328-330 |
Buy |
| A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets |
Rice Stephen P
|
Mar/Apr 2002 |
120-122 |
Buy |
| Basics of Compounding: Parenteral Preparations |
Allen Loyd V Jr
|
Nov/Dec 2001 |
441-447 |
Buy |
| Total Parenteral Nutrition Solution |
Allen Loyd V Jr
|
Nov/Dec 2001 |
458 |
Buy |
| Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II |
Zhang Yanping, Xu Quanyun, Trissel Lawrence A, Baker Mary B
|
Sep/Oct 1999 |
415-420 |
Buy |
| Parenteral Nutrition Equipment and Devices |
Bertch Karen E
|
Sep/Oct 1998 |
338-341 |
Buy |
| Catheter Occlusion: Causes and Solutions |
McKinnon Barbara, Lima Hetty A
|
Sep/Oct 1998 |
342-346 |
Buy |
| TPN Bulk Compounding from Bulk Drug Substances |
Chamallas Stanley N
|
Sep/Oct 1998 |
347-349 |
Buy |
| The Feasibility and Benefits of TPN in Horses: A Review of the Findings |
Paoletti James E, Downing Dee, Tormo Vicente J
|
Sep/Oct 1998 |
351-353 |
Buy |
| Adult Peripheral Parenteral Nutrition Solution with 4.23% Amino Acids |
Allen Loyd V Jr
|
Sep/Oct 1998 |
366 |
Buy |
| Adult Peripheral Parenteral Nutrition Solution with 2.5% Amino Acids |
Allen Loyd V Jr
|
Sep/Oct 1998 |
367 |
Buy |
| Pediatric Central Parenteral Nutrition Solution |
Allen Loyd V Jr
|
Sep/Oct 1998 |
368 |
Buy |
| Pediatric Central Parenteral Nutrition Solution with Heparin |
Allen Loyd V Jr
|
Sep/Oct 1998 |
369 |
Buy |
| Pediatric Peripheral Parenteral Nutrition Solution |
Allen Loyd V Jr
|
Sep/Oct 1998 |
370 |
Buy |
| Three-in-One Adult Total Parenteral Nutrition |
Allen Loyd V Jr
|
Sep/Oct 1998 |
371 |
Buy |
| Testing for Bacterial Endotoxins |
Jelinek Todd
|
Sep/Oct 1998 |
379 |
Buy |
| Standard Operating Procedure for Quality Assessment of Parenteral Nutrition Products |
Allen Loyd V Jr
|
Sep/Oct 1998 |
380-381 |
Buy |
| Parenteral Admixture Incompatibilities:An Introduction |
Allen Loyd V Jr
|
May/Jun 1997 |
165-167 |
Buy |
